Do physician incentives increase patient medication adherence?

Area of Science:

• Health Services Research
• Behavioral Economics
• Clinical Pharmacy

Background:

• Patient medication adherence is crucial for managing chronic conditions like diabetes, hypertension, and high cholesterol.
• Physician financial incentives are increasingly explored as a strategy to improve healthcare outcomes, including medication adherence.

Purpose of the Study:

• To evaluate the effectiveness of financial incentives for physicians in enhancing patient adherence to medications for diabetes, antihypertensives, and statins.
• To determine if physician-targeted incentives can overcome barriers to medication adherence.

Main Methods:

• A randomized controlled trial involving 911 primary care practices and 8,935 nonadherent patients.
• Analysis of pharmacy and medical claims data from a Medicare Advantage Prescription Drug Plan (2011-2012).
• Measurement of patient medication adherence (proportion of days covered) for 18 months pre-intervention and 6 months post-intervention.

Main Results:

• No statistically significant increase in medication adherence was observed across the three drug classes (diabetes, antihypertensives, statins) following the introduction of physician incentives.
• The study ruled out increases in medication adherence greater than 4.2 percentage points.

Conclusions:

• Financial incentives of $50 per patient per drug class were ineffective in improving patient medication adherence in the studied population and setting.
• The findings suggest that incentives may not influence patient behaviors, which are often outside direct physician control.
• Further research is needed to explore alternative incentive structures or interventions to effectively improve medication adherence.